Skip to main content

Clinical trial SIENDO/ENGOT-EN5

A randomized phase III trial of maintenance with Selinexor / placebo after combination chemotherapy for patients with advanced or recurrent endometrial cancer

Cancers
Organ Endomètre
Trial status Trial open for recruitment
Investigator
Trial type
Interventional with experimental drug
Phase Trial phase 3
Academic trial Non
Sponsor Karyopharm
EudraCT Identifier 2017-000607-25
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03555422
Last update